Allergan (AGN)
|
107.63
+1.45 (+1.37%)
|
|
|
|
AGN additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
AGN Profile
•
Exchange
NYSE
•
Top Holders (By Fund)
ASTON/Montag & Caldwell Growth N
Oppenheimer Capital Appreciation Y
Oppenheimer Capital Appreciation B
Oppenheimer Capital Appreciation C
Oppenheimer Capital Appreciation N
Oppenheimer Capital Appreciation A
ASTON/Montag & Caldwell Growth R
ASTON/Montag & Caldwell Growth I
Vanguard US Growth Inv
Vanguard US Growth Adm
Oppenheimer Capital Appreciation Y
Oppenheimer Capital Appreciation B
Oppenheimer Capital Appreciation C
Oppenheimer Capital Appreciation N
Oppenheimer Capital Appreciation A
ASTON/Montag & Caldwell Growth R
ASTON/Montag & Caldwell Growth I
Vanguard US Growth Inv
Vanguard US Growth Adm
•
Top Holders (By Family)
•
Executives
Mr. David E. I. Pyott
Chairman
Chief Exec. officer and Pres
Mr. Jeffrey L. Edwards
Chief Financial Officer and Exec. VP of Fin. & Bus. Devel.
Mr. Douglas S. Ingram J.D. q.
49
Exec. VP Pres of Europe Africa & Middle East and Chairman of Corp. Governance & Compliance Committee
Dr. Scott M. Whitcup M.D.
Chief Scientific Officer and Exec. VP of R&D
Mr. David J. Endicott
Corp. VP and Pres of Allergan Medical
Asia Pacific & Latin America
Chairman
Chief Exec. officer and Pres
Mr. Jeffrey L. Edwards
Chief Financial Officer and Exec. VP of Fin. & Bus. Devel.
Mr. Douglas S. Ingram J.D. q.
49
Exec. VP Pres of Europe Africa & Middle East and Chairman of Corp. Governance & Compliance Committee
Dr. Scott M. Whitcup M.D.
Chief Scientific Officer and Exec. VP of R&D
Mr. David J. Endicott
Corp. VP and Pres of Allergan Medical
Asia Pacific & Latin America
•
Employee Count
10,500
Special Offers
Competitors
AGN earnings
Date
Actual
Expected
Prev Yr Qtr
10/30/2012
1.06
1.04
0.92
8/1/2012
1.07
1.06
0.96
5/2/2012
0.86
0.87
0.77
